Environmental and genetic risk factors for retinal angiomatous proliferation-Reference-Cited by-同舟云学术

Environmental and genetic risk factors for retinal angiomatous proliferation

Published:2014-05-22 Issue:8 Volume:92 Page:745-748
ISSN:1755-375X
Container-title:Acta Ophthalmologica
language:en
Short-container-title:Acta Ophthalmol

Author:

Caramoy Albert¹,Ristau Tina¹,Lechanteur Yara T.²,Ersoy Lebriz¹,Müller Sebastian³,Gelisken Faik³,Hoyng Carel B.²,Kirchhof Bernd¹,den Hollander Anneke I.²,Fauser Sascha¹

Affiliation:

1. Department of Ophthalmology; University Hospital of Cologne; Cologne Germany

2. Department of Ophthalmology; Radboud University Nijmegen Medical Centre; Nijmegen The Netherlands

3. Center for Ophthalmology; University of Tuebingen; Tuebingen Germany

Publisher

Wiley

Subject

Ophthalmology,General Medicine

Reference12 articles.

1. Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis;Chakravarthy;BMC Ophthalmol,2010

2. HTRA1 promoter polymorphism in wet age-related macular degeneration;Dewan;Science,2006

3. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk;Hageman;Hum Mol Genet,2005

4. CFH and ARMS2 variations in age-related macular degeneration, polypoidal choroidal vasculopathy, and retinal angiomatous proliferation;Hayashi;Invest Ophthalmol Vis Sci,2010

5. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk;Rivera;Hum Mol Genet,2005

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential key role of choroidal non-perfusion and rod degeneration in the pathogenesis of macular neovascularization type 3;Eye;2024-03-18

2. Current Perspectives on Type 3 Macular Neovascularization due to Age-Related Macular Degeneration;Ophthalmologica;2024

3. Histology of Type 3 Macular Neovascularization and Microvascular Anomalies in Treated Age-Related Macular Degeneration;Ophthalmology Science;2023-09

4. Do patients with unilateral macular neovascularization type 3 need AREDS supplements to slow the progression to advanced age-related macular degeneration?;Eye;2022-09-29

5. Histology of type 3 macular neovascularization and microvascular anomalies in treated age-related macular degeneration: a case study;2022-09-15